Compound ID | 1111
Class: Beta-lactam (cephalosporin)
| Spectrum of activity: | Gram-positive & Gram-negative |
| Description: | D.A. Preston et al.Preclinical Bacteriological evaluation of LY164846, A New Orally Absorbed Cephalosporin Antibiotic [Abstract 229]" Programs and abstracts of the 24th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington.DC. American Society for Microbiology. 1984. |
| Institute where first reported: | The Lilly Research Laboratories |
| Year first mentioned: | 1984 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| Reason Dropped: | High levels of Nephrotoxicity shown in mice |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/13339667 |
| Citation: |